Name,Alias,Ab or Nb,Protein+Epitope,Epitope class,Binds to,Not Bind to,Neutralising Vs,Not Neutralising Vs,,,,,,,,,,,,,,,,,,,,,,,,,Live Virus Neutralisation IC50 (50% titre; ¦Ìg/ml)ãÐÖµ2¦Ìg/ml,Live Virus Neutralisation IC80 (80% titre; ¦Ìg/ml),Live Virus Neutralisation IC90 (90% titre; ¦Ìg/ml),Live Virus Neutralisation IC100 (100% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC50 (50% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC80 (80% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC90 (90% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC100 (100% titre; ¦Ìg/ml),Pseudo Virus Neutralisation (fold change),Source,Source-update,Notes,Origin,VH or VHH,VL,Heavy V Gene,Heavy J Gene,Light V Gene,Light J Gene,CDRH3,CDRL3,PDB
47D11,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT and SARS-CoV1,,,,,,,,,,,,,,,,,,,,,,,,,,0.57;0.19(SARS)[Chunyan Wang et al.£» 2020],,,,0.061;0.061(SARS)[Chunyan Wang et al.£» 2020] && 0.063;0.059(K417N);0.078(E484K);0.054(N501Y)[Juliette Fedry et al.£» 2020],,,,,Chunyan Wang et al.£» 2020 (https://www.nature.com/articles/s41467-020-16256-y) && Juliette Fedry et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.09.30.318261v1.full.pdf+html),,Complete,B-cells; SARS-CoV1 Human Patient,QVQLQESGPGLVKPSETLSLTCSVSGGSISSHYWSWIRQPPGKGLEWIGYIYYSGSTNHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGVLLWFGEPIFEIWGQGTMVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSSLAWYQQKPGQAPRLLIYGASTRAPGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEI,IGHV4-59 (Human),IGHJ3 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGVLLWFGEPIFEI,QQYNNWPLT,https://www.rcsb.org/structure/7AKD;https://www.rcsb.org/structure/7AKJ
A19-46-1,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1,SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0398(WA-1)£»0.0203(D614G)£»0.0115(B.1.1.7)£»0.0571(B.1.135 v2)£»0.0232(P.1)£»>10(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0194(D614G)£»0.0392(B.1.1.7)£»0.057(B.1.361)£»0.0397(P.1)£»>10.0(B.1.617.2)£»0.223(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.1287(WA-1)£»0.0435(D614G)£»0.025(B.1.1.7)£»0.1572(B.1.135 v2)£»0.0749(P.1)£»>10(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0406(D614G)£»0.106(B.1.1.7)£»0.157(B.1.361)£»0.0696(P.1)£»>10.0(B.1.617.2)£»0.376(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Lingshu Wang et al.£» 2021 (https://www.science.org/doi/10.1126/science.abh1766) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTLSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGWAYWELLPDYYYGMDVWGQGTTVTVSS,QTVVTQEPSFSVSPGGTVTLTCGLSSGSVSTAYFPSWYQQTPGQAPRTLIYGTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGRGIVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV8-61 (Human),IGLJ3 (Human),ARGWAYWELLPDYYYGMDV,VLYMGRGIVV,https://www.rcsb.org/structure/7TC9;https://www.rcsb.org/structure/7TCA;https://www.rcsb.org/structure/7TCC;https://www.rcsb.org/structure/7U0D
A19-61-1,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SRAS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,SARS-CoV2_WT;SARS-CoV2_Alpha;SRAS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0709(WA-1)£»0.0128(D614G)£»0.0111(B.1.1.7)£»0.0108(B.1.135 v2)£»0.0187(P.1)£»0.0283(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0077(D614G)£»0.0313(B.1.1.7)£»0.0108(B.1.361)£»0.0073(P.1)£»0.0187(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.1633(WA-1)£»0.0261(D614G)£»0.0186(B.1.1.7)£»0.0196(B.1.135 v2)£»0.0303(P.1)£»0.041(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0201(D614G)£»0.0494(B.1.1.7)£»0.0196(B.1.361)£»0.015(P.1)£»0.0275(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Lingshu Wang et al.£» 2021 (https://www.science.org/doi/10.1126/science.abh1766) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAFHWVRQAPGKGLEWVAVISYDGSNQYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDLAIAVAGTWHYYNGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVIITCRASQGISSWLAWYQQKPGKAPKVLIYDASSLQSGVPSRFSGSGYGTDFTLTISSLQPEDSATYYCQQAKSFPITFGQGTRLEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ5 (Human),ARDLAIAVAGTWHYYNGMDV,QQAKSFPIT,https://www.rcsb.org/structure/7TB8;Expected (7TBF)
A23-58-1,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1 (weak),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0025(WA-1)£»0.0018(D614G)£»<0.0006(B.1.1.7)£»0.0016(B.1.135 v2)£»0.0007(P.1)£»0.0016(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0013(D614G)£»0.0021(B.1.1.7)£»0.0047(B.1.361)£»0.0016(P.1)£»0.0016(B.1.617.2)£»0.231(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.0107(WA-1)£»0.0049(D614G)£»0.0039(B.1.1.7)£»0.0091(B.1.135 v2)£»0.0032(P.1)£»0.0035(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0045(D614G)£»0.0047(B.1.1.7)£»0.0116(B.1.361)£»0.0057(P.1)£»0.0035(B.1.617.2)£»1.132(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Lingshu Wang et al.£» 2021 (https://science.sciencemag.org/content/early/2021/06/30/science.abh1766) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPNCSNVVCYDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYSASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGTSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPNCSNVVCYDGFDI,QQYGTSPWT,https://www.rcsb.org/structure/7LRS;https://www.rcsb.org/structure/7LRT
ab1,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.2[Wei Li et al.£» 2020],,,0.4[Wei Li et al.£» 2020],6.2nM[Zehua Sun et al. 2021],,,,,Dhiraj Mannar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.19.473380v1) && Jianhui Nie et al.£» 2021 (https://www.nature.com/articles/s41421-021-00292-z) && US10822379B1 (https://patents.google.com/patent/US10822379B1/en) && Wei Li et al.£» 2020 (https://www.pnas.org/content/117/47/29832) && Zehua Sun et al. 2021 (https://www.biorxiv.org/content/10.1101/2021.03.22.436481v1),,Variant binding data in Zehua Sun et al. Complete,Phage Display (Ab£» human£» non-immune),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARGYGDYYFDYWGQGTLVTVSS,DVVMTQSPATLSLSPGEKATLSCRASQSVSSYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYGSSPLTFGGGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-15 (Human),IGKJ4 (Human),ARGYGDYYFDY,QQYGSSPLT,https://www.rcsb.org/structure/7MJJ;https://www.rcsb.org/structure/7MJK;https://www.rcsb.org/structure/7MJL
B1-182-1,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1 (weak),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0034(WA-1)£»0.0008(D614G)£»<0.0006(B.1.1.7)£»0.0007(B.1.135 v2)£»0.0003(P.1)£»0.001(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0009(D614G)£»0.0017(B.1.1.7)£»0.002(B.1.361)£»<0.0006(P.1)£»0.001(B.1.617.2)£»0.281(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.0088(WA-1)£»0.0026(D614G)£»0.0024(B.1.1.7)£»0.0026(B.1.135 v2)£»0.0015(P.1)£»0.0035(B.1.617.2)[Lingshu Wang et al.£» 2021] && 0.0024(D614G)£»0.0039(B.1.1.7)£»0.0043(B.1.361)£»0.0015(P.1)£»0.0035(B.1.617.2)£»1.301(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Lingshu Wang et al.£» 2021 (https://www.science.org/doi/10.1126/science.abh1766) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCFDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGFPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPWTFGQGTKVEIR,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSGGSCFDGFDI,QQYGNSPWT,https://www.rcsb.org/structure/7MLZ;https://www.rcsb.org/structure/7MM0;https://www.rcsb.org/structure/7TB8;https://www.rcsb.org/structure/7TBF;https://www.rcsb.org/structure/7TCC;https://www.rcsb.org/structure/7U0D
BD-812,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Kappa,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Kappa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.016nM(D614G);0.013nM(Alpha);0.010nM(Beta);0.0097nM(B.1.617.1);0.011nM(B.1.617.2)[CN113512114A] && 0.016nm(D614G)£»0.013nm(B.1.1.7)£»0.01nm(B.1.351)£»0.009nm(B.1.617.1)£»0.011nm(B.1.617.2)[Shuo Du et al.£» 2021],,,,,CN113512114A (https://patents.google.com/patent/CN113512114A/en) && Shuo Du et al.£» 2021 (https://www.nature.com/articles/s41422-021-00555-0),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVQSGAEVKKPGESLKISCQFSEYKLISFWIAWVRQRPGKGLEWMGIIYPDDSDTKYSPSSQGQVTISADKSIRTAYLQWSSLMASDTAMYYCTSGSYYGTLDFWGQGTLVTVSS,DIEITQSPSSLSASVGDRVTISCRASQDIRTYVAWYQQRPGKVPRLLIYAASTLQSGVPSRFSGRGSGTDFTLTISSLQPEDVATYYCQQYNSAPLTFGGGAKVEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV1-27 (Human),IGKJ4 (Human),TSGSYYGTLD,QQYNSAPLT,https://www.rcsb.org/structure/7EZV
BD-836,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Kappa,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Kappa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.013nM(D614G);0.015nM(Alpha);0.0073nM(Beta);0.010nM(B.1.617.1);0.0053nM(B.1.617.2)[CN113512114A] && 0.013nm(D614G)£»0.015nm(B.1.1.7)£»0.007nm(B.1.351)£»0.010nm(B.1.617.1)£»0.005nm(B.1.617.2)[Shuo Du et al.£» 2021],,,,,CN113512114A (https://patents.google.com/patent/CN113512114A/en) && Shuo Du et al.£» 2021 (https://www.nature.com/articles/s41422-021-00555-0),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVRVSCKASGFTFSTSAVQWVRQARGQRLEWIGWIAVGSGKTDYLQKFQERVTMTRDESTNTAYMQLSSLRSEDTAVYYCAAPHCSGGTCYDGFDIWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRSGYFAWYQQRPGRAPRLLIYGASSRATAIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQQYGTSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSGGTCYDGFDI,QQYGTSPWT,https://www.rcsb.org/structure/7EZV
C022,,Ab,S; RBD,¢ô,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.173(D614G);0.255(Alpha);0.455(Beta);0.250(Epsilon);0.377(Lota);0.173(SARS);0.063(WIV1);0.007(SHC014)[Claudia Jette et al.£» 2021],,,,0.07(D614G);0.06(R683G)£»0.036(R346S);0.011(V367F);0.07(K417N);0.07(N439K);0.04(N444R);0.048(V445E);0.108(L455R);0.06(A475V);0.09(S477R);0.126(E484K/R683G);0.068(Q493R);0.045(N501Y);0.051(V503F)[Claudia Jette et al.£» 2021] && 0.07357252529385716[Davide Robbiani et al.£» 2020],0.31471039979824[Davide Robbiani et al.£» 2020],0.7368679715897201[Davide Robbiani et al.£» 2020],,,Claudia Jette et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.04.23.441195v1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9)£» Claudia Jette et al.£» 2021 (https://www.cell.com/action/showPdf?pii=S2211-1247%2821%2901214-6),Claudia Jette et al.£» 2021 (https://linkinghub.elsevier.com/retrieve/pii/S2211124721012146),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLQESGPGLVKPSETLSVTCTVSGGSISSSRYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHAAAYYDRSGYYFIEYFQHWGQGTLVTVSS,DIQMTQSPSTLSASVGDSVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNNYRYTFGQGTKLEIK,IGHV4-39 (Human),IGHJ1 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARHAAAYYDRSGYYFIEYFQH,QQYNNYRYT,https://www.rcsb.org/structure/7RKU
C051,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.012510825018362726[Christian Gaebler et al.£» 2021] && 0.025[Frauke Muecksch et al.£» 2021],,0.091689631767115[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQAGGSLRLSCAASGFGVRNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTVFLQMNRLRAEDTAVYYCAREGDVEGFSDLWSGYSRDRYYFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITFSCTGTSSDVGGYNYVSWYQQYPGKAPKLLIYDVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSFTSSNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGFSDLWSGYSRDRYYFDY,SSFTSSNTRV,https://www.rcsb.org/structure/7R8N
C052,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.004888485305936[Christian Gaebler et al.£» 2021] && <0.01[Frauke Muecksch et al.£» 2021],,0.027790745547917647[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIRPGGSLRLSCAASGFSVSNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFNISRDNSKNTVYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGALVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSNNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,NSYTSNNTRV,ND
C053,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.008231907835966005[Christian Gaebler et al.£» 2021],,0.039801235561270146[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFIVSNNYMSWVRQAPGKGLDWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYHDSWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGSSSDVGGYNFVSWYQQHPGRAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQVEDEADYYCSSYTNNNTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,SSYTSSSARV,ND
C054,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.00483530762519026[Christian Gaebler et al.£» 2021],,0.015448767585701401[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYDADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSARVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGDVEGYYDFWSGYSRDRYYFDY,SSYTSSSARV,ND
C055,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.006396151623189075[Christian Gaebler et al.£» 2021] && <0.01[Frauke Muecksch et al.£» 2021],,0.0368251095623654[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Following up for full sequence,B-cells; SARS-CoV2_WT Human Patient,ND,ND,IGHV3-66 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARDSSEVRDHPGHPGRSVGAFDI,CSYAGSHTFV,ND
C080,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.044283339553540996[Christian Gaebler et al.£» 2021] && 0.1~1[Frauke Muecksch et al.£» 2021],,1.8884469558483301[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVQSGAEVKKPGESLNISCKASGYSFTIYWIAWVRQLPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWRSLKASDSAVYYCARGVAVDWYFDLWGRGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCAGSSSNIGAGFDVYWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSSGSVLSDLYVFGTGTKVTVL,IGHV5-51 (Human),IGHJ2 (Human),IGLV1-40 (Human),IGLJ1 (Human),ARGVAVDWYFDL,QSSGSVLSDLYV,https://www.rcsb.org/structure/7N3F
C098,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.47859684976238454[Christian Gaebler et al.£» 2021] && 1~2.5[Frauke Muecksch et al.£» 2021],,4.246677518442439[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYSSGGTDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLYSSGGTDI,QQYGSSPGT,https://www.rcsb.org/structure/7N3G;https://www.rcsb.org/structure/7N3I
C099,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.027230489548285452[Christian Gaebler et al.£» 2021] && 0.01~0.1[Frauke Muecksch et al.£» 2021],,0.0860809026741215[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVMYAGGSTFYADSVKGRFTISRDDSKNTLFLQMNSLRAEDTAIYYCARDLYSSGGTDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSIGSSYLAWYQQKPGLAPRLLIYGASRRATGIPDKFSGSGSGADFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDLYSSGGTDI,QQYGSSPGT,https://www.rcsb.org/structure/7N3H;https://www.rcsb.org/structure/7R8L
C118,,Ab,S; RBD,¢ô,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT (weak),,,,,,,,,,,,,,,,,,,,,,,,,,0.44(D614G);0.316(Alpha);0.706(Beta);0.359(Epsilon);0.464(Lota);3.89(SARS);0.055(WIV1);0.169(SHC014)[Claudia Jette et al.£» 2021],,,,0.114(D614G);0.086(R683G)£»0.075(R346S);0.044(V367F);0.118(K417N);0.075(N439K);0.088(N444R);0.063(V445E);0.131(L455R);0.111(A475V);0.123(S477R);0.168(E484K/R683G);0.122(Q493R);0.076(N501Y);0.046(V503F)[Claudia Jette et al.£» 2021] && 0.103685237111368[Davide Robbiani et al.£» 2020],0.417755740282364[Davide Robbiani et al.£» 2020],>1[Davide Robbiani et al.£» 2020],,,Claudia Jette et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.04.23.441195v1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9),Claudia Jette et al.£» 2021 (https://linkinghub.elsevier.com/retrieve/pii/S2211124721012146),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCASGYTGYDYFVRGDYYGLDVWGQGTTVTVSS,QPVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNTDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGILVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV4-69 (Human),IGLJ3 (Human),ASGYTGYDYFVRGDYYGLDV,QTWGTGILV,https://www.rcsb.org/structure/7RKV
C512,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.05222782140222394[Christian Gaebler et al.£» 2021] && 0.1[Frauke Muecksch et al.£» 2021],,0.27499458026864104[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Following up for full sequence,B-cells; SARS-CoV2_WT Human Patient,ND,ND,IGHV4-4 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),AKGGDTAMGPEYFDY,SSFASSSTLL,ND
C548,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.03050616030571115[Christian Gaebler et al.£» 2021] && 0.01~0.1[Frauke Muecksch et al.£» 2021],,0.20718860503118902[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARREAYGPRDYYYYYGMDVWGQGTTVTVSS,QSAVLTQPPSASASLGASVTLTCTLSSGYSNYKVDWYQQRPGKGPRFVMRVGTGGIVGSKGDGIPDRFSVLGSGLNRYLTIKNIQEEDESDYHCGADQGSGSNFVGVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARREAYGPRDYYYYYGMDV,GADQGSGSNFVGV,https://www.rcsb.org/structure/7R8O
C549,,Ab,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.01407370585773675[Christian Gaebler et al.£» 2021] && 0.01~0.1[Frauke Muecksch et al.£» 2021],,0.0320866930279093[Christian Gaebler et al.£» 2021],,,Christian Gaebler et al.£» 2021 (https://www.nature.com/articles/s41586-021-03207-w) && Frauke Muecksch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321002946),,Variant binding data in paper. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTSAISWVRQAPGQGLEWMGGIIPFFGTPNYAQKFQGRVTIIADESTTTAYMELSGLRFEDSAVYYCARREPYGPRDYYYFFGMDVWGPGTTVTVSS,QSAVLTQPPFASASLGASVTLTCTLSSDYSYYKVDWYQQRPGKGPRFVIRVGPGGIVGSKGDGFPDRFSVLGSGLNRSLTINNIQEEDEGDYHCGADEGSGGTFVGVFGGGTKLTVL,IGHV1-69 (Human),IGHJ6 (Human),IGLV9-49 (Human),IGLJ3 (Human),ARREPYGPRDYYYFFGMDV,GADEGSGGTFVGV,ND
CC40.8,,Ab,S; S2,,SARS-CoV1;SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV1 (weak);SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12.6;26.7(SARS)[Ge Song et al.£» 2021] && 12(WT)£»13(Alpha)£»13(Beta)£»7(Gamma)£»6(Delta)[Panpan Zhou et al.£» 2021],,,,,Ge Song et al.£» 2021 (https://www.nature.com/articles/s41467-021-23074-3#Sec18) && Panpan Zhou et al.£» 2021 (https://www.science.org/doi/full/10.1126/scitranslmed.abi9215),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYVMTWARQAPGKGLEWVSAISGTGYTYYADSVKGRFTVSRDNSKNTLFLQMSSLRAEDTAVYYCAITMAPVVWGQGTTVTVSS,SYELTQPPSVSVSPGQTARITCSGDALPKRYAYWYQQKSGQAPILVIYEDKKRPSGIPERLSGSKSGTVATLTISGAQVEDEADYYCYSTDSSGNHAVFGGGTQLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-10 (Human),IGKJ3 (Human),AITMAPVV,YSTDSSGNHAV,https://www.rcsb.org/structure/7SJS
CDC-A10,,Ab,S; S1 non-RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0268[Lingshu Wang et al.£» 2018],0[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSTYALSWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELNSLRSEDTAVYYCARGSRSSSSAEYFQHWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSYTLEWFGGGTKLTVL,IGHV1-69 (Human),IGHJ1 (Human),IGLV2-11 (Human),IGLJ3 (Human),ARGSRSSSSAEYFQH,CSYAGSYTLEW,ND
CDC-A2,,Ab,S; S1 non-RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.218[Lingshu Wang et al.£» 2018],0[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Email sent£» awaiting author reply.,B-cells; MERS-CoV Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGLGSGWYDWFDPWGQGTLVTVSS,QSALTQPPSVSGAPGQRVTISCTGSSSNIGASYDVHWYQHLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWFSGGTKLTVL,IGHV3-11 (Human),IGHJ5 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARVGLGSGWYDW,QSYDSSLSGW,ND
CDC-C2,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0057[Lingshu Wang et al.£» 2018],0.012199999999999999[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSIYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGGHQGYCSGGSCYDFDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPAFGGGTKLEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV2-28 (Human),IGKJ4 (Human),AREGGHQGYCSGGSCYDFDY,MQALQTPA,https://www.rcsb.org/structure/6C6Z
CDC-C5,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.056299999999999996[Lingshu Wang et al.£» 2018],0.056299999999999996[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,B-cells; MERS-CoV Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASLLRPLIYCSGGSCTDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWCQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSNITLVFGTGTKVTVL,IGHV4-39 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ASLLRPLIYCSGGSCTDY,SSYTSNITLV,ND
COV2-2333,,Ab,S; S2,¢ñ,SARS-CoV1;SARS-CoV2_WT,,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Elaine Chen et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.05.02.442326v1) && Seth Zost et al.£» 2020 (https://www.nature.com/articles/s41591-020-0998-x),Elaine Chen et al.£» 2021 (https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01042-1),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSIYWMSWVRQAPGKGLQWVANIKQDASEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGSSWHFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDKLGDKYSSWYQQKPGQSPVLVIYEDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWSSSTAVFGGGTKLTVL,IGHV3-7 (Human),IGHJ4 (Human),IGLV3-1 (Human),IGLJ3 (Human),ARLGGSSWHFDY,QAWSSSTAV,ND
COV2-2489,,Ab,S; NTD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT (weak),,,,,,,,,,,,,,,,,,,,,,,,,,0.199[Naveenchandra Suryadevara et al.£» 2021] && >3.333[Seth Zost et al.£» 2020],,,,,,,,,Naveenchandra Suryadevara et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.01.19.427324v1) && Seth Zost et al.£» 2020 (https://www.nature.com/articles/s41591-020-0998-x),,Complete,B-cells; SARS-CoV2_WT Human Patient,QLQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWGWIRQPPGKGLEWIASIYYSGSTYYNPSLKSRLTVSVDTSKNQFSLKLSSVTAADTAVYYCARQWKWFGEAWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERASLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPFTFGGGTKVEIK,IGHV4-39 (Human),IGHJ2 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARQWKWFGEAWYFDL,QQYGSSPFT,ND
COV2-2676,,Ab,S; non-RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT (weak),,,,,,,,,,,,,,,,,,,,,,,,,,0.501[Naveenchandra Suryadevara et al.£» 2021] && >3.333[Seth Zost et al.£» 2020],,,,,,,,,Naveenchandra Suryadevara et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.01.19.427324v1) && Seth Zost et al.£» 2020 (https://www.nature.com/articles/s41591-020-0998-x),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTFTADESTSTAYMEVSSLRSEDTAVYYCARSCGDCYSADLDFWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSISSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQRRSNWPPFTFGPGTKVDIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARSCGDCYSADLDF,QRRSNWPPFT,ND
COVA2-04,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,,,,,,,,,,,,,,,,,,,,,,,,,0.22[Nicholas Wu] && 2.5[Philip Brouwer et al.£» 2020],,,,2.5[Nicholas Wu] && 0.22[Philip Brouwer et al.£» 2020],,,,,Nicholas Wu (https://www.biorxiv.org/content/10.1101/2020.07.26.222232v1) && Philip Brouwer et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc5902),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLERAGGMDVWGQGTMVTVSS,EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYTFGQGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARDLERAGGMDV,QQYGSLYT,https://www.rcsb.org/structure/7JMO
COVA2-14,,Ab,S; non-RBD,,SARS-CoV1;SARS-CoV2_WT,,,SARS-CoV1;SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Payton Weidenbacher et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.24.477625v1) && Philip Brouwer et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc5902),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARVRYYDSSGYYEDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQEPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPMYTFGQGTKVEIK,IGHV1-69 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARVRYYDSSGYYEDY,QQRSNWPPMYT,ND
COVA2-39,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1;SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,0.036[Nicholas Wu] && 0.054[Philip Brouwer et al.£» 2020],,,,0.054[Nicholas Wu] && 0.036[Philip Brouwer et al.£» 2020],,,,,Nicholas Wu (https://www.biorxiv.org/content/10.1101/2020.07.26.222232v1) && Philip Brouwer et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc5902),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYTGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAHVDTAMVESGAFDIWGQGTRVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVTKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL,IGHV3-53 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARAHVDTAMVESGAFDI,CSYAGSSTWV,https://www.rcsb.org/structure/7JMP
COVOX-150,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.023[Wanwisa Dejnirattisai et al.£» 2021] && 0.012(Victoria)£»0.139(Alpha)£»0.35(Beta)£»0.04(Gamma)£»0.02(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYSGGTTYYADSVKGRFTISRDSSMNTLYLQMNSLRAEDTAVYYCARDLMVYGIDVWGQGTTVTVSS,EIVMTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPPGYTFGQGTKVDIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLMVYGIDV,QQLDSYPPGYT,https://www.rcsb.org/structure/7BEI;https://www.rcsb.org/structure/7ND5
COVOX-158,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta (weak);SARS-CoV2_Gamma (weak);SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.034[Wanwisa Dejnirattisai et al.£» 2021] && 0.031(Victoria)£»0.254(Alpha)£»>10(Beta)£»>10(Gamma)£»0.026(Delta)£»>10(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.cell.com/cell/fulltext/S0092-8674(21)01578-6),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLGSGDMDV,QQLNSYRYT,https://www.rcsb.org/structure/7BEJ;https://www.rcsb.org/structure/7BEK;https://www.rcsb.org/structure/7QNY
COVOX-222,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,0.019[Wanwisa Dejnirattisai et al.£» 2021],,,,,,,,,Chang Liu et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1931312821005199) && Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421004281),,Solved in complex with multiple variants. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLGAEDTAVYYCARGEGSPGNWFDPWGQGTLVTVSS,DVVMTQSPGTLSLSPGERATLSCRASQSVPSSYLAWYQQKPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDTSPRFGGGTKVDIK,IGHV3-53 (Human),IGHJ5 (Human),IGKV3-20 (Human),IGKJ3 (Human),ARGEGSPGNWFDP,QHYDTSPR,https://www.rcsb.org/structure/7NX6; https://www.rcsb.org/structure/7NX7; https://www.rcsb.org/structure/7NX8; https://www.rcsb.org/structure/7NX9; https://www.rcsb.org/structure/7NXA; https://www.rcsb.org/structure/7NXB; https://www.rcsb.org/structure/7OR9;https://www.rcsb.org/structure/7Q9G
COVOX-253,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,0.04[Wanwisa Dejnirattisai et al.£» 2021] && 0.055(Victoria)£»0.126(Alpha)£»0.109(Beta)£»0.137(Gamma)£»0.005(Delta)£»1.063(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Chang Liu et al.£» 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00755-8) && Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Variant binding and neutralisation data in Liu et al. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIQMTQSPGTLSLSPGEGATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSGATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPYT,https://www.rcsb.org/structure/7BEN;https://www.rcsb.org/structure/7ORA
COVOX-253H165L,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.003[Wanwisa Dejnirattisai et al.£» 2021] && 0.003(Victoria)£»0.006(Alpha)£»0.013(Beta)£»0.019(Gamma)£»0.007(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIVMTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASRRGTGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPWT,https://www.rcsb.org/structure/7NDB
COVOX-253H55L,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,0.004[Wanwisa Dejnirattisai et al.£» 2021] && 0.003(Victoria)£»0.008(Alpha)£»0.009(Beta)£»0.026(Gamma)£»0.003(Delta)£»2.945(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS,DIQMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFGVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCNSTSCYDAFDI,QQYGSSPWT,https://www.rcsb.org/structure/7BEO;https://www.rcsb.org/structure/7ND9;https://www.rcsb.org/structure/7NDA
COVOX-269,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Delta,SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.036[Wanwisa Dejnirattisai et al.£» 2021] && 0.03(Victoria)£»>10.0(Alpha)£»>10.0(Beta)£»>10.0(Gamma)£»0.021(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X)£» Piyada Supasa et al.£» 2021 (https://www.cell.com/cell/pdf/S0092-8674(21)00222-1.pdf) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGLTVNRNYMSWIRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAIYYCARDFYEGSFDIWGQGTMVTVSS,AIQLTQSPSFLSASIGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFASYYCQQLNSYPAPVFGPGTKVDIK,IGHV3-53 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDFYEGSFDI,QQLNSYPAPV,https://www.rcsb.org/structure/7BEM;https://www.rcsb.org/structure/7NEG;https://www.rcsb.org/structure/7NEH
COVOX-316,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1;SARS-CoV2_Beta;SARS-CoV2_Gamma,,,,,,,,,,,,,,,,,,,,,,,,,0.01[Wanwisa Dejnirattisai et al.£» 2021] && 0.018(Victoria)£»0.024(Alpha)£»>10.0(Beta)£»>10.0(Gamma)£»0.008(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYTQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYSCARDMAFSMVRGSFDYWGQGTLVTVSS,QAVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNHWVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-8 (Human),IGLJ3 (Human),ARDMAFSMVRGSFDY,SSYAGSNHWV,https://www.rcsb.org/structure/7BEH;https://www.rcsb.org/structure/7ND7
COVOX-384,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1;SARS-CoV2_Beta;SARS-CoV2_Gamma,,,,,,,,,,,,,,,,,,,,,,,,,0.002[Wanwisa Dejnirattisai et al.£» 2021] && 0.004(Victoria)£»0.005(Alpha)£»>10.0(Beta)£»>10.0(Gamma)£»0.108(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMTWIRQAPGKGLEWVSYIRSSGHTIYYADSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCARGGVLRFLEWPLNAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNNALGTFGQGTKVEIK,IGHV3-11 (Human),IGHJ3 (Human),IGKV1-27 (Human),IGKJ1 (Human),ARGGVLRFLEWPLNAFDI,QKYNNALGT,https://www.rcsb.org/structure/7BEP;https://www.rcsb.org/structure/7ND8
COVOX-40,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,0.026[Wanwisa Dejnirattisai et al.£» 2021] && 0.026(Victoria)£»0.035(Alpha)£»0.738(Beta)£»0.153(Gamma)£»0.029(Delta)£»7.989(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ1 (Human),ARDLGSGDMDV,QQLNSYRYT,https://www.rcsb.org/structure/7ND6
COVOX-45,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Beta,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.005[Wanwisa Dejnirattisai et al.£» 2021],,,,,,,,,Chang Liu et al.£» 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00755-8) && Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X),,Variant binding and neutralisation data in Liu et al. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVLSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGSYAYYYYMDVWGKGTTVTVSS,DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGGGSGTDFTFTITSLQPEDIATYYCQQYDNLPLTFGGGTKVDIK,IGHV3-30-3 (Human),IGHJ6 (Human),IGKV1-33 (Human),IGKJ4 (Human),AKGGSYAYYYYMDV,QQYDNLPLT,https://www.rcsb.org/structure/7BEL;https://www.rcsb.org/structure/7ORA;https://www.rcsb.org/structure/7ORB;https://www.rcsb.org/structure/7PRY
COVOX-88,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1;SARS-CoV2_Beta;SARS-CoV2_Gamma,,,,,,,,,,,,,,,,,,,,,,,,,0.033[Wanwisa Dejnirattisai et al.£» 2021] && 0.033(Victoria)£»0.058(Alpha)£»>10.0(Beta)£»>10.0(Gamma)£»0.039(Delta)£»>10.0(Omicron)[Wanwisa Dejnirattisai et al.£» 2022],,,,,,,,,Wanwisa Dejnirattisai et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S009286742100221X) && Wanwisa Dejnirattisai et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S0092867421015786),,Complete,B-cells; SARS-CoV2_WT Human Patient,QLQLQESGPGLVKPSQTLSLTCTVSGGSISSGSYNWTWIRQPAGKGLEWIGRIYNSGSTNYNPSLKSRVTISVDTSKNQLSLKVRSVTAADTAVYYCARHCSGGTCYPKYYYGMDVWGQGTTVTVSS,QSALTQPPSVSEAPRQRVTISCSGSSSNIGNNAVNWYQQFPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGVQSEDEADYYCAAWDDSLNVVVFGGGTKLTVL,IGHV4-61 (Human),IGHJ6 (Human),IGLV1-36 (Human),IGLJ3 (Human),ARHCSGGTCYPKYYYGMDV,AAWDDSLNVVV,https://www.rcsb.org/structure/7BEL;https://www.rcsb.org/structure/7ND4
CV30,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron;WIV-1;SARS-CoV1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron;WIV-1;SARS-CoV1,,,,,,,,,,,,,,,,,,,,,,,,,0.020(Wuhan-Hu1)£»0.020(Alpha)£»0.280(Beta)£»0.120(Gamma)£»0.010(Delta)£»>5(Omicron)£»>50(WIV1)[Nicholas Hurlburt et al.£» 2022],,,,0.03[Emilie Seydoux et al.£» 2020],,,,,Emilie Seydoux et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.05.12.091298v1) && Nicholas Hurlburt et al.£» 2022 (https://www.nature.com/articles/s42003-022-03262-7),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVSGGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKLEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDLDVSGGMDV,QQYGSSPQT,http://www.rcsb.org/structure/6XE1
DH1046,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT;WIV-1;RsSHC014,MERS-CoV;OC43;NL63;229E,SARS-CoV1;SARS-CoV2_WT;WIV-1;RsSHC014,MERS-CoV;OC43;NL63;229E,,,,,,,,,,,,,,,,,,,,,,,,,1.086[Dapeng Li et al.£» 2021],9.383[Dapeng Li et al.£» 2021],,,0.396[Dapeng Li et al.£» 2021],2.03[Dapeng Li et al.£» 2021],,,,Dapeng Li et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2020.12.31.424729v1) && David Martinez et al.£» 2021 (https://www.science.org/doi/10.1126/scitranslmed.abj7125),,Complete,B-cells; SARS-CoV1 Human Patient,EVQLVESGGGMVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLEWVSAISGSGIRTYYAESVKGRVTISRDNSKSTLYLQMNSLRAEDTAVYYCAKDLFYDFWSGFDFGPGESFGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVNITCRVSQRITSWLAWYQQKPGKAPKVLISKTSSLEGGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYSEFSYTFGQGTKLEIK,IGHV3-23 (Human),IGHJ6 (Human),IGKV1-5 (Human),IGKJ2 (Human),AKDLFYDFWSGFDFGPGESFGMDV,QQYSEFSYT,ND
DH1073,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT;WIV-1,MERS-CoV;OC43;NL63;229E;RsSGC014,SARS-CoV1;SARS-CoV2_WT;WIV-1,MERS-CoV;OC43;NL63;229E;RsSGC014,,,,,,,,,,,,,,,,,,,,,,,,,3.218[Dapeng Li et al.£» 2021],14.51[Dapeng Li et al.£» 2021],,,6.79[Dapeng Li et al.£» 2021],43.13[Dapeng Li et al.£» 2021],,,,Dapeng Li et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2020.12.31.424729v1) && David Martinez et al.£» 2021 (https://www.science.org/doi/10.1126/scitranslmed.abj7125),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVRKPGASVKVSCKASGYTFTDYYIHWVRQAPGQGLEWMGIINPEAGSTTSAQRFQGRLIMTTDTSASTVYMELNSLTSADTAVYYCARDYFLIPAANTMEVWGQGTTVTVSS,EIVLTQSPDTLSLSPGERATLSCRASQSVGTYLAWFQQKPGQPPRLLIYDASNRATGIPARFGGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPRTWTFGQGTKVEIK,IGHV1-46 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDYFLIPAANTMEV,QQRSNWPRTWT,ND
Fab_15033,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.489[Shane Miersch et al.£» 2021],,,,,Shane Miersch et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.11.02.466984v1) && Shane Miersch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S0022283621004101),,Complete,Phage Display (Ab£» human£» non-immune),EVQLVESGGGLVQPGGSLRLSCAASGFDLGGYSMHWVRQAPGKGLEWVAGIYASGGATAYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARSYYYGGFGMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASDLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQSYRYPITFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARSYYYGGFGMDY,QQSYRYPIT,https://www.rcsb.org/structure/7KLG
Fab_15033-7,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.016[Shane Miersch et al.£» 2021] && 0.083[Shane Miersch et al.£» 2021],,,,,Shane Miersch et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.11.02.466984v1) && Shane Miersch et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S0022283621004101),,Complete,Engineered from Phage Display (antibody£» non-immune),EVQLVESGGGLVQPGGSLRLSCAASGFDLGGYSMHWVRQAPGKGLEWVAGIYASGGATAYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARSYYYGGFGMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASDLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQSHTYPITFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARSYYYGGFGMDY,QQSHTYPIT,https://www.rcsb.org/structure/7KXJ; https://www.rcsb.org/structure/7KXK;https://www.rcsb.org/structure/7KML;https://www.rcsb.org/structure/7KMK; https://www.rcsb.org/structure/7KLH
FIB-H1,,Ab,S; S1 non-RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0083[Lingshu Wang et al.£» 2018],0[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Email sent£» awaiting author reply.,Immunised Rhesus Macaques,EVQLVQSGAEVKKPGASVKVSCKASGHIFTSYVINWLQAEPGQGFEWMGGIHPGNGGRDYAQKFQGRVTITADMSTSTVYMELRSLRSEDMAVYYCAASSGSYGVSSLDVWGRGVLVTVSS,QSALTQPPSLSASPGASARLPCTLSSDLSVGSKNMYWYQQKPGSAPRLFLYYYSDSDKQLGPGVPNRVSGSKETSSNTAFLLISGLQPEDEADYYCQVYDSSANWVFGGGTRLTVL,IGHV1-69 (Human),IGHJ2 (Human),IGLV11-1 (Rhesus),IGLJ2 (Rhesus),AASSGSYGVSSLDV,QVYDSSANWV,ND
GW01,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV1;SARS-CoV2_WT,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0199;0.0567(SARS);0.002(WIV1);0.0015(RS3367)[CN111793129A] && 0.0254;0.0186(Alpha);0.0165(N501Y);0.182(D405A);0.2782(A435G);1.02(G446V);0.03585(A475V);0.25(T478I);0.04345(F486A);>50(E309D);>50(F342L);>50(A372T);>50(T376A);>50(R491A);>50(K386A);>50(IS69V);0.01933(SARS);0.00377(WIV-1)[CN113173995A],,,,,CN111793129A (https://patents.google.com/patent/CN111793129A/en) && CN113173995A (https://patents.google.com/patent/CN113173995A/en),,*May neutralise omicron when used in bispecific (https://www.biorxiv.org/content/10.1101/2022.01.30.478305v1). Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGVVQPGGSLRLSCAASGFRFDDHAMHWVRQAPGKGLEWVSVISGDGGSTYYADSVKGRFSISRDDSKNSLYLQMNSLRTEDTALYYCAKDRSYGPPDVFNYEYGMDVWGQGTTVTVSS,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNWVFGGGTKLTVL,IGHV3-43 (Human),IGHJ6 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDRSYGPPDVFNYEYGMDV,AAWDDSLNWV,ND
JC57-11,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0096[Lingshu Wang et al.£» 2018],0.034[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,Immunised Rhesus Macaques,EVQLLESGPGVVRPSETLSLSCAVSGGSISDSYRWSWIRQPPGKGLEWVGYIFATGTTTNYNPSLKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCAREPFKYCSGGVCYAHKDNSLDVWGQGVLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIHSASSRATGIPDRFSGSGSGTEFSLTISSLEAEDVGVYHCYQHSSGYTFGPGTKLDIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV3-9 (Rhesus),IGKJ1 (Rhesus),AREPFKYCSGGVCYAHKDNSLDV,YQHSSGYT,ND
JC57-13,,Ab,S; S1 non-RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0085[Lingshu Wang et al.£» 2018],0.0787[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,Immunised Rhesus Macaques,QVQLQESGPGLVKPSETLSLTCAVSGGSISSNYWNWIRQSPGKGLEWIGYIYGGSGSTTYNPSLKSRVAISTDTSKDQFSLKLSSVTAADTAVYYCARLLPLGGGYCFDYWGQGVLVTVSS,DIVMTQTPFTLPVTPGEAASISCRSSQSLFDSDYGNTYLDWYLQKPGQSPQLLIYMLSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGLYYCMQSVEYPFTFGPGTKLDIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV2S17 (Rhesus),IGKJ1 (Rhesus),ARLLPLGGGYCFDY,MQSVEYPFT,ND
JC57-14,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.008400000000000001[Lingshu Wang et al.£» 2018],0.0308[Lingshu Wang et al.£» 2018],,,,Lingshu Wang et al.£» 2018 (https://jvi.asm.org/content/92/10/e02002-17) && WO2016138160 (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016138160),,Complete,Immunised Rhesus Macaques,QVQLQESGPGLVKPSETLSLTCAVSGDSISSNYWSWIRQPPGKGLEWIGRFSGSGGSTDFNPSLKSRVTISTDTSKNQFSLNLRSVTAADTAVYYCAKTYSGTFDYWGQGVLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDINNYLSWYQQKPGKAPKPLIYYASSLETGVPSRFSGSRSGTDYTLTISSLQLEDFATYYCQQYNNSPYSFGQGTKVEIK,IGHV4-2 (Rhesus),IGHJ5-2 (Rhesus),IGKV1S15 (Rhesus),IGKJ1 (Rhesus),AKTYSGTFDY,QQYNNSPYS,https://www.rcsb.org/structure/6C6X; https://www.rcsb.org/structure/6C6Y
JMB2002,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1,SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.00425[Chunyin Gu et al.£» 2021] && 0.036(WT)£»0.024(Alpha)£»0.170(Beta)£»0.094(Gamma)£»0.150(Omicron)[Yin et al.£» 2022],,,,,Chunyin Gu et al.£» 2021 (https://www.tandfonline.com/doi/full/10.1080/19420862.2021.1930636) && Yin et al.£» 2022 (https://www.science.org/doi/10.1126/science.abn8863),,In Phase-I clinical trials at time of Yin et al. 2022.,Phage Display Library (scFv£» naive£» non-immune),QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCASLASYSSGWEDVFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV1-33 (Human),IGKJ4 (Human),ASLASYSSGWEDVFDI,QQYDNLPLT,https://www.rcsb.org/structure/7WPD;https://www.rcsb.org/structure/7WPE;https://www.rcsb.org/structure/7WPF;https://www.rcsb.org/structure/7WRV
MR17,,Nb,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12.32[Hebang Yao et al.£» 2020] && 12.32[Tingting Li et al.£» 2020],,,,,Hebang Yao et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.09.24.312595v1.full.pdf) && Tingting Li et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.09.143438v1),Hebang Yao et al.£» 2020 (https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009328),Complete,Phage Display (Nanobody£» non-immune),QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVSS,QVQLVESGGGLVQAGGSLRLSCAASGFPVWQGEMAWYRQAPGKEREWVAAISSMGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVMVGFWYAGQGTQVTVS,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),,,NVKDDGQLAYHYDY,,https://www.rcsb.org/structure/7C8W;https://www.rcsb.org/structure/7D30
MR3,,Nb,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.4[Hebang Yao et al.£» 2020] && 0.4[Tingting Li et al.£» 2020],,,,,Hebang Yao et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.09.24.312595v1.full.pdf) && Tingting Li et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.09.143438v1),Hebang Yao et al.£» 2020 (https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009328),Complete,Phage Display (Nanobody£» non-immune),QVQLVESGGGLVQAGGSLRLSCAASGFPVNAHFMYWYRQAPGKEREWVAAIYSYGRTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGAASWEYDYWGQGTQVTVSS,QVQLVESGGGLVQAGGSLRLSCAASGFPVWQGEMAWYRQAPGKEREWVAAISSMGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVMVGFWYAGQGTQVTVS,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),,,NVKDYGAASWEYDY,,ND
MR6,,Nb,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.32[Hebang Yao et al.£» 2020],,,,,Hebang Yao et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.09.24.312595v1.full.pdf) && Tingting Li et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.09.143438v1),Hebang Yao et al.£» 2020 (https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009328),Complete,Derived from MR17£»Phage Display (Nanobody£» non-immune),QVQLVESGGGLVQAGGSLRLSCAASGFPVEDTWMEWYRQAPGKEREWVAAITSWGFKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGDTSASYDYWGQGTQVTVSS,QVQLVESGGGLVQAGGSLRLSCAASGFPVWQGEMAWYRQAPGKEREWVAAISSMGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVMVGFWYAGQGTQVTVS,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),,,NVKDEGDTSASYDY,,ND
Nb105,,Nb,S; RBD,¢ò,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.079599[Yufei Xiang et al.£» 2020],,,,0.0801485[Yufei Xiang et al.£» 2020],,,,,Dapeng Sun et al.£» 2021 (https://www.nature.com/articles/s41467-021-24963-3) && Yufei Xiang et al.£» 2020 (https://science.sciencemag.org/content/early/2020/11/04/science.abe4747),,Variant binding data in Sun et al. Complete,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAVSGRTFSTYGMAWFRQAPGKERDFVATITRSGETTLYADSVKGRFTISRDNAKNTVYLQMNSLKIEDTAVYYCAVRRDSSWGYSRDLFEYDYWGQGTQVTVSS ,,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),,,AVRRDSSWGYSRDLFEYDY,,https://www.rcsb.org/structure/7MDW;https://www.rcsb.org/structure/7ME7
Nb17,,Nb,S; RBD,¢ó,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.023549999999999998[Yufei Xiang et al.£» 2020],,,,0.0173642[Yufei Xiang et al.£» 2020],,,,,Dapeng Sun et al.£» 2021 (https://www.nature.com/articles/s41467-021-24963-3) && Yufei Xiang et al.£» 2020 (https://science.sciencemag.org/content/early/2020/11/04/science.abe4747),,Variant binding data in Sun et al. Complete,Immunised Llama,HVQLVESGGGLVQAGGSLRLSCAASGSIFSSNAMSWYRQAPGKQRELVASITSGGNADYADSVKGRFTISRDKNTVYPEMSSLKPADTAVYYCHAVGQEASAYAPRAYWGQGTQVTVSS ,,IGHV3S53 (Alpaca),IGHJ4 (Alpaca),,,HAVGQEASAYAPRAY,,https://www.rcsb.org/structure/7ME7;https://www.rcsb.org/structure/7N9T
Nb21,,Nb,S; RBD,¢ñ,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.0003454[Yufei Xiang et al.£» 2020],,,,0.0007064999999999999[Yufei Xiang et al.£» 2020],,,,,Dapeng Sun et al.£» 2021 (https://www.nature.com/articles/s41467-021-24963-3) && Yufei Xiang et al.£» 2020 (https://science.sciencemag.org/content/early/2020/11/04/science.abe4747),,Variant binding data in Sun et al. Complete,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAVSGLGAHRVGWFRRAPGKEREFVAAIGANGGNTNYLDSVKGRFTISRDNAKNTIYLQMNSLKPQDTAVYYCAARDIETAEYTYWGQGTQVTVSS ,,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),,,AARDIETAEYTY,,https://www.rcsb.org/structure/7N9A;https://www.rcsb.org/structure/7N9B;https://www.rcsb.org/structure/7MDW;https://www.rcsb.org/structure/7MEJ
Nb34,,Nb,S; RBD,¢ò,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.017662499999999998[Yufei Xiang et al.£» 2020],,,,0.0312587[Yufei Xiang et al.£» 2020],,,,,Dapeng Sun et al.£» 2021 (https://www.nature.com/articles/s41467-021-24963-3) && Yufei Xiang et al.£» 2020 (https://science.sciencemag.org/content/early/2020/11/04/science.abe4747),,Variant binding data in Sun et al. Complete,Immunised Llama,DVQLVESGGGLVQAGGSLRLSCAASGFTFSNYVMYWGRQAPGKGREWVSGIDSDGSDTAYASSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCVKSKDPYGSPWTRSEFDDYWGQGTQVTVSS ,,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),,,VKSKDPYGSPWTRSEFDDY,,https://www.rcsb.org/structure/7N9E
Nb95,,Nb,S; RBD,¢ò,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.0801485[Yufei Xiang et al.£» 2020],,,,0.157785[Yufei Xiang et al.£» 2020],,,,,Dapeng Sun et al.£» 2021 (https://www.nature.com/articles/s41467-021-24963-3) && Yufei Xiang et al.£» 2020 (https://science.sciencemag.org/content/early/2020/11/04/science.abe4747),,Variant binding data in Sun et al. Complete,Immunised Llama,QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYSMGWFRQAQGKEREFVATINGNGRDTYYTNSVKGRFTISRDDATNTVYLQMNSLKPEDTAIYYCAADKDVYYGYTSFPNEYEYWGQGTQVTVSS,,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),,,AADKDVYYGYTSFPNEYEY,,https://www.rcsb.org/structure/7N9C
NIH-CoVnb-112,,Nb,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14.3nM(Prototype)£» 9.4nM(Alpha)£» 15.8nM(Beta)£» 17.6nM(Gamma)£» 14.5nM(Delta)[Thomas Esparza et al.£» 2021],,,,,Thomas Esparza et al.£» 2020 (https://www.nature.com/articles/s41598-020-79036-0) && Thomas Esparza et al.£» 2021 (https://www.tandfonline.com/doi/full/10.1080/19420862.2022.2047144),,Complete. Neutralisation assays to come in future study,Immunised Llama,DVQLQESGGGLVQPGGSLRLSCAASGLTLDYYAIGWFRQAPGKEREGVSCISSSDGSTYYADSVKGRFTTSRDNAKNTVYLQMNSLKPEDTAVYYCAAVPSTYYSGTYYYTCHPGGMDYWGKGTQVTVSS,,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),,,AAVPSTYYSGTYYYTCHPGGMDY,,https://www.rcsb.org/structure/7RBY
P008_056,,Ab,S; NTD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.03[Annachiara Rosa et al.£» 2021] && /[Carl Graham et al.£» 2021],,1.56[Annachiara Rosa et al.£» 2021],,,,,,,Annachiara Rosa et al.£» 2021 (https://advances.sciencemag.org/content/early/2021/04/22/sciadv.abg7607) && Carl Graham et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S1074761321001357),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVKPGGSLRLSCAASGFSFSSYSMNWVRQAPGKGLEWVSSISSNSNYIYYADSMKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASNRSPYDSSNYYFDYWGQGTRVTISS,AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQHHDSLPLTFGGGTKVEIK,IGHV3-21 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ASNRSPYDSSNYYFDY,QHHDSLPLT,https://www.rcsb.org/structure/7NTC
Regdanvimab,CT-P59,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.27575(Gamma)[Dong Kyun-Ryu et al.£» 2021] && n.n.(Omicron)[Franck Touret et al.£» 2022] && 0.002(D614G);>10(B.1.1.529)[Laura VanBlargan et al.£» 2021],,,,0.000219(D614G);0.01345(Gamma);0.000154(K417N);0.003273(E484K);0.001202(N501Y)[Dong Kyun-Ryu et al.£» 2021],,,,,Cheolmin Kim et al.£» 2021 (https://www.nature.com/articles/s41467-020-20602-5) && Dong Kyun-Ryu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.07.08.451696v1) && Franck Touret et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.01.474639v1) && INN Proposed List P124 (https://www.who.int/medicines/publications/druginformation/innlists/PL124-COVID.pdf) && Laura VanBlargan et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.15.472828v1) && Matthew McCallum et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.28.474380v1) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1) && Xun Wang et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.24.474138v1),,Therapeutic mAb. Also known as CT-P59. Variant binding data in Ryu et al. Complete,Phage Display (Ab£» human£» immune - SARS-CoV2),QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,IGHV2-70 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARIPGFLRYRNRYYYYGMDV,GTWDSSLSAGV,https://www.rcsb.org/structure/7CM4
S109,,Ab,S; RBD,,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,0.424;(Early_GZ02);0.848(Middle_CUHK-W1);3.392(Late_Urbani)[Barry Rockx et al.£» 2008],,,,,,,,,Barry Rockx et al.£» 2008 (https://jvi.asm.org/content/jvi/82/7/3220.full.pdf) && Dora Pinto et al.£» 2020 (https://www.nature.com/articles/s41586-020-2349-y),Barry Rockx et al.£» 2008 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268459/),Email sent£» awaiting author reply.,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGLV3-25 (Human),ND,ARLESATQPLGYYFYGMDV,HSADISATSWV,ND
S227,,Ab,S; RBD,,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,0.019;(Early_GZ02);0.077(Middle_CUHK-W1);0.153(Late_Urbani)[Barry Rockx et al.£» 2008],,,,,,,,,Barry Rockx et al.£» 2008 (https://jvi.asm.org/content/jvi/82/7/3220) && Dora Pinto et al.£» 2020 (https://www.nature.com/articles/s41586-020-2349-y),Barry Rockx et al.£» 2008 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268459/),Email sent£» awaiting author reply.,B-cells; SARS-CoV1 Human Patient,ND,ND,IGHV3-23 (Human),ND,IGKV1-5 (Human),ND,ASPLRNYGDLLY,QQYNSYSWT,ND
S230,,Ab,S; RBD,,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,0.020;(Early_GZ02);0.040(Middle_CUHK-W1);0.160(Late_Urbani)[Barry Rockx et al.£» 2008],,,,,,,,,Barry Rockx et al.£» 2008 (https://jvi.asm.org/content/jvi/82/7/3220) && Dora Pinto et al.£» 2020 (https://www.nature.com/articles/s41586-020-2349-y),Barry Rockx et al.£» 2008 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268459/),Complete,B-cells; SARS-CoV1 Human Patient,QAQLVESGGALVQPGRSLRLSCAASGFTFRNYAMHWVRQAPATGLQWLAVITSDGRNKFYADSVKGRFTISREDSKNTLYLQMDSLRGEDTAVYYCVTQRDNSRDYFPHYFHDMDVWGQGTTVAVSS,VLTQSPLSLPVTLGQPASISCRSSQSLVYSDGDTYLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGSHWPPTFGQGTKVEIK,IGHV3-30 (Human),IGHJ6 (Human),IGKV2-30 (Human),IGKJ1 (Human),VTQRDNSRDYFPHYFHDMDV,MQGSHWPPT,https://www.rcsb.org/structure/6NB6; https://www.rcsb.org/structure/6NB7; https://www.rcsb.org/structure/6NB8
S2D106,,Ab,S; RBD,¢ña£»1,SARS-CoV2_WT,SARS-CoV2_Omicron-BA1,SARS-CoV2_WT,SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,0.007[Tyler Starr et al.£» 2021],,,0.0091;>10(Omicron)[Elisabetta Cameroni et al.£» 2021],0.004(VSV pp)[Tyler Starr et al.£» 2021],,,,,Elisabetta Cameroni et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.12.472269v1) && Tyler Starr et al.£» 2021 (https://www.nature.com/articles/s41586-021-03807-6),Elisabetta Cameroni et al.£» 2021 (https://www.nature.com/articles/s41586-021-04386-2),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVQSGAEVKKPGSSVKVSCKASGGPFSSSAISWVRQAPGQGLEWMGGIIPMVGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDSRYCSGGSCYSVWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKVLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEMK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARDSRYCSGGSCYSVWFDP,QQSYSTPRT,https://www.rcsb.org/structure/7R7N
S2H97,,Ab,S; RBD,¢õ£» NA,SARS-CoV2_WT;SARS-CoV2_Omicron-BA1 (weak),,SARS-CoV2_WT;SARS-CoV2_Omicron-BA1 (weak),,,,,,,,,,,,,,,,,,,,,,,,,,0.749[Tyler Starr et al.£» 2021],,,0.28;1.368(Omicron)[Elisabetta Cameroni et al.£» 2021],0.338(VSV pp)[Tyler Starr et al.£» 2021],,,,,Elisabetta Cameroni et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.12.472269v1) && M Alejandra Tortorici et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.04.07.438818v1) && Tyler Starr et al.£» 2021 (https://www.nature.com/articles/s41586-021-03807-6),Elisabetta Cameroni et al.£» 2021 (https://www.nature.com/articles/s41586-021-04386-2),Variant binding data in publication. Complete,B-cells; SARS-CoV2_WT Human Patient,QVRLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTVYLQWSSLKASDTAMYYCARQWSHYTYDYYYWGQGTLVTISS,QSVLTQPASVSGSPGQSITISCTGISSDVGGYNSVSWYQQHPGKAPKLMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPPYVFGTGTKVSVL,IGHV5-51 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARQWSHYTYDYYY,SSYTSSSTPPYV,https://www.rcsb.org/structure/7M7W
S3H3,,Ab,S; SD1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Delta (weak);SARS-CoV2_Omicron-BA1,,,,,,,,,,,,,,,,,,,,,,,,,,0.457[Shiqi Xu et al.£» 2022],,,,0.083[Shiqi Xu et al.£» 2022],,,,,PDB (to be published) && Shiqi Xu et al.£» 2022 (https://www.tandfonline.com/doi/full/10.1080/22221751.2021.2024455),,Awaiting publication for antibody origin and variant binding/neutralisation profiles,Immunised Mouse,QVQLQQPGAELVRPGASVKLSCKASGYSFTRFWMNWVKQRPGQGLEWIGMIHPSDSETRLNQKFKDKATLTVDKSSTTAYMQLSSPTSEDSAVYYCARKDYDYDAWFAYWGQGTLVTVSA,DIVLTQSPASLAVSLGQRATISCRASKSVSASVYSYMHWYQQKPGQPPKLLIYLASSLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCHHSRELPPAFGGGTKLEIK,IGHV1-61 (Mouse),IGHJ3 (Mouse),IGKV3-12 (Mouse),IGKJ1 (Mouse),ARKDYDYDAWFAY,HHSRELPPA,https://www.rcsb.org/structure/7WK8;https://www.rcsb.org/structure/7WKA;https://www.rcsb.org/structure/7WD8;https://www.rcsb.org/structure/7WD9;https://www.rcsb.org/structure/7WDF;https://www.rcsb.org/structure/7WK9
STE90-C11,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,EP3919126A1 (https://patents.google.com/patent/EP3919126A1/en) && Federico Bertoglio et al.£» 2021 (https://www.nature.com/articles/s41467-021-21609-2),,Complete,Phage Display (Ab£» human£» immune - SARS-CoV2),QVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARDVADAFDIWGQGTMVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPFTFGPGTKVDIK,IGHV3-66 (Human),IGHJ3 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDVADAFDI,QQLNSYPPFT,https://www.rcsb.org/structure/7B3O
Ty1,,Nb,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha,,SARS-CoV2_WT;SARS-CoV2_Alpha,SARS-CoV2_Beta;SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Leo Hanke et al.£» 2020 (https://www.nature.com/articles/s41467-020-18174-5) && Mert Golcuk et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.04.23.441186v1) && Ryota Maeda et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.10.25.465714v1.full.pdf),,Complete,Immunised Alpaca,QVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNIGYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS,,IGHV3S1 (Alpaca),IGHJ4 (Alpaca),,,AIGLNLSSSSV,,https://www.rcsb.org/structure/6ZXN
Wu_Nb22,,Nb,S; RBD,,SARS-CoV2_Delta;SARS-CoV2_WT,,SARS-CoV2_Delta;SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0016[Xilin Wu et al.£» 2021],0.0086[Xilin Wu et al.£» 2021],,,,PDB (to be published) && Xilin Wu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.02.08.429275v1) && Xilin Wu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.09.06.459055v1),,Complete,Immunised Alpaca,QVQLVESGGNLVQPGGSLRLSCAASGGTLASFAVGWFRQAPGKEREGVSCIDVINRANYADSVKGRFTISRDSAKNTVYLQMNSLEPEDTAVYSCAAHFVPPGSRLRGCLVNELYNYWGQGTQVTVSS,,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),,,AAHFVPPGSRLRGCLVNELYNY,,https://www.rcsb.org/structure/7X7D
1000000000,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,3.21,,,,,,,,,Xian-Chun Tang et al.£» 2014 (https://www.pnas.org/content/pnas/111/19/E2018.full.pdf),,Complete,Phage Display (Ab£» human£» non-immune),QVQLVQSGGGVVQPGRSLRLSCVASEFTFNTYGMHWVRQAPGKGLEWVAAISYDGTKKFYADSLKGRFTISRDNSKNTLYLQMNSLRSEDTAVYYCARSGDSDAFDIWGQGTMVTVSS,SYELTQPPSVSVSPGQTATITCSGDELGDKFAFWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQALDEADYYCQAWDSNSYVFGTGTKVTVL,IGHV3-30 (Human),IGHJ3 (Human),IGLV3-1 (Human),IGLJ1 (Human),ARSGDSDAFDI,QAWDSNSYV,ND
0304-3H3,,Ab,S; S2,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,0.11,,,,,,,,,Xiangyang Chi et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/19/science.abc6952/tab-pdf),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGPGLVKPSETLSLTCTASGGSISTYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRIAPVGKFFGWYFDLWGRGTLVTVSS,DIVMTQSPATLSVSPEERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNKWPPWTFGQGTKVDIK,IGHV4-59 (Human),IGHJ2 (Human),IGKV3-15 (Human),IGKJ1 (Human),ARDRIAPVGKFFGWYFDL,QQYNKWPPWT,ND
16L9,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,SARS-CoV2_Omicron-BA1*,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0041,,,,,Yingdan Wang et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.30.478305v1),,*May neutralise omicron when used in bispecific (https://www.biorxiv.org/content/10.1101/2022.01.30.478305v1). Awaiting publication for full sequence.,B-cells (SARS-CoV2 Human Patient),ND,ND,IGHV3-53 (Human),ND,IGLV2-8 (Human),ND,ARGEIQPYYYYGMDV,SSYAGSSNFDV,Expected
1F8,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,6.27,,,,,,,,,Xian-Chun Tang et al.£» 2014 (https://www.pnas.org/content/pnas/111/19/E2018.full.pdf),,Complete,Phage Display (Ab£» human£» non-immune),EVQLVQSGAEVKEPGSSVKVSCKASGGTFGSYAINWVRQAPGQRLEWMGWIDAANGNTKYSQKFQGRVTITGDTSASTAYMELSSLRSEDTAVYYCARDRWMTTRAFDIWGQGTMVTVSS,QPVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVFWYQQLPGMAPKLLISRNNQRPSGVPDRFSGSKSGTSASLAISGPQSEDEADYYCAAWDDSLRGPVFGGGTRVTVL,IGHV1-3 (Human),IGHJ3 (Human),IGLV1-47 (Human),IGLJ6 (Human),ARDRWMTTRAFDI,AAWDDSLRGPV,ND
1G10E4E2,,Ab,S; Unk,,MERS-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,KR20200020411 (https://patentimages.storage.googleapis.com/ce/72/67/21080e9221767b/WO2020036403A1.pdf),,Complete,Immunised Mouse,QVQLEQSGAELVRPGASVTVSCKASGYTFTDYEMHWVKQTPVHGLEWIGAIDPETGGTAYNQKFKGKATLTADKSSSTAYMELRSLTSEESAVYYCTRPSSYDAMDYWGQGTSVTVSS,DIVLTQSTLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSHVPYTFGGGTKLEIK,IGHV11-2 (Mouse),IGHJ3 (Mouse),IGKV1-117 (Mouse),IGKJ1 (Mouse),TRPSSYDAMDY,FQGSHVPYT,ND
Xu_Nb30,,Nb,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0996;0.0817(bivalent);0.0707(trimer),,,,,Jianliang Xu et al.£» 2021 (https://www.nature.com/articles/s41586-021-03676-z),,Neutralised all variants tested in monomeric form. Complete,Transgenic Mouse ("nanomouse"),QVQLVESGGGLVQAGGSLRLSCAASGLTFSKYAMGWFRQAPGKERKFVATISWSGDSAFYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAADRGMGYGDFMDYWGQGTSVTASS,,IGHV3-3 (Alpaca),IGHJ7 (Alpaca),QVQLVESGGGLVQAGGSLRLSCAASGLTFSKYAMGWFRQAPGKERKFVATISWSGDSAFYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAADRGMGYGDFMDYWGQGTSVTASS,,AADRGMGYGDFMDY,,https://www.rcsb.org/structure/7MY2
Xu_Nb56,,Nb,S; RBD,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0137;0.0046(bivalent);0.0039(trimer),,,,,Jianliang Xu et al.£» 2021 (https://www.nature.com/articles/s41586-021-03676-z),,Neutralised some VoC when mulitmerised. Complete,Immunised Llama,QVQLQESGGGLVQAGDSLRLSCVASERTFRRYGMGWFRQAPGKEREFVAAVDRSHTKTGYADFVKGRFTISTNYENMVYLQMNSLKPEDTAVYYCAAPSYEKGSDPTSWNTDRGYDYWGQGTQVTVSS,,IGHV3-3 (Alpaca),IGHJ4 (Alpaca),,,AAPSYEKGSDPTSWNTDRGYDY,,ND
YK-CoV-01,YK-CoV2-01,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.00057(Alpha+20A .EU1),,,,,CN112794899B (https://patents.google.com/patent/CN112794899B/en),,Complete,B-cells (SARS-CoV2 Human Patient),EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYTGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREESDFVLVPAARGGMDVWGQGTTVTVSS,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYVGSNKWVFGGGTKLTVL,IGHV3-66 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),AREESDFVLVPAARGGMDV,SSYVGSNKWV,ND
YK-CoV2-02,,Ab,S; RBD,RBM,SARS-CoV2_WT;SARS-CoV2_Alpha,,SARS-CoV2_WT;SARS-CoV2_Alpha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.00057(D614G);0.00012(Alpha+D615G),,,,,CN112794898B (https://patents.google.com/patent/CN112794898B/en),,Complete,B-cells (SARS-CoV2 Human Patient),QVQLVESGGGLIQPGGSLRLSCAVSGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNDNSKNTLYLQMNSLRAEDTAVYYCARDWVRGSNWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSNYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQERSNWPSGTFGPGTKVDIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-11 (Human),IGKJ3 (Human),ARDWVRGSN,QERSNWPSGT,ND
YU536-D04,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,EP3919126A1 (https://patents.google.com/patent/EP3919126A1/en),,Complete,Phage Display (Ab£» human£» immune - CoV2_WT),QVQLVQSGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVMGLDVWGKGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPITFGQGTKLEIK,IGHV3-66 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ5 (Human),ARDLVVMGLDV,QQLNSYPIT,ND
YU537-H11,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,EP3919126A1 (https://patents.google.com/patent/EP3919126A1/en),,Complete,Phage Display (Ab£» human£» immune - CoV2_WT),EVQLLESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNALYLQMNSLREADTAVYYCARGESGSPYGMDVWGQGTLVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDTNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCATWDSSLSVGVFGGGTKLTVL,IGHV3-53 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARGESGSPYGMDV,ATWDSSLSVGV,ND
ZWD12,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta,,,,,,,,,,,,,,,,,,,,,,,,,,0.103;0.069(Beta);0.079(Delta),,,,0.00586;0.004107(Alpha);0.003564(Beta);0.003829(Gamma);0.007287(Delta),,,,,CN113735969A (https://patents.google.com/patent/CN113735969A/en),,Complete,B-cells (SARS-CoV2 Vaccinated Human),EVQLVESGGGLVQPGGTLRLSCVASGFSFSNYWMSWVRQAPGKGLEWVANIKQDGSETHYVDSVKGRFTISRDNAKNSLYLQMNSLRADDTAVYFCVKDRTDWELIRGYFGHWGQGTQITVSS,DIVMTQTPSSLSLSPGDRATLSCRASENIINYLAWYQQRPGQSPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRIIWPPYTFGQGTKVDIK,IGHV3-7 (Human),IGHJ1 (Human),IGKV3-11 (Human),IGKJ3 (Human),VKDRTDWELIRGYFGH,QQRIIWPPYT,ND
